Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bruker

39.35
-0.7100-1.77%
Post-market: 39.350.00000.00%19:09 EDT
Volume:1.79M
Turnover:70.88M
Market Cap:5.97B
PE:51.84
High:40.25
Open:40.03
Low:38.61
Close:40.06
Loading ...

Bruker Introduces Innovative Fourier 80 Multinuclear Benchtop FT-NMR

Business Wire
·
07 Apr

Bruker Corp : Citigroup Cuts Target Price to $50 From $75

THOMSON REUTERS
·
07 Apr

Should You Think About Buying Bruker Corporation (NASDAQ:BRKR) Now?

Simply Wall St.
·
05 Apr

Bruker Introduces Breakthrough d-DNP Polarizer: Stock to Gain?

Zacks
·
03 Apr

Bruker Announces Introduction of Revolutionary d-DNP Polarizer for MRI Research and for Dynamic Nuclear Polarization Liquids NMR

Business Wire
·
02 Apr

3 Reasons to Sell BRKR and 1 Stock to Buy Instead

StockStory
·
31 Mar

Is Bruker Corporation (BRKR) an Oversold Value Stock to Buy According to Hedge Funds?

Insider Monkey
·
27 Mar

Bruker Corporation (BRKR): Among Michael Burry’s Top Holdings

Insider Monkey
·
18 Mar

Based On Its ROE, Is Bruker Corporation (NASDAQ:BRKR) A High Quality Stock?

Simply Wall St.
·
17 Mar

BioSpin's Innovations to Support Bruker Shares, Macro Issues to Ail

Zacks
·
14 Mar

Bruker Stock Acquisition: A Strategic Move by CAO Bures Thomas

TIPRANKS
·
12 Mar

Bruker Stock to Benefit From the Launch of X4 POSEIDON Benchtop XRM

Zacks
·
06 Mar

Is Bruker Corporation (BRKR) the Best Medical Technology Stock to Buy According to Analysts?

Insider Monkey
·
05 Mar

Bruker’s Promising Market Position and Growth Prospects Justify Buy Rating

TIPRANKS
·
03 Mar

Bruker Launches X4 POSEIDON™ Advanced X-Ray Microscope for Three-Dimensional Microscopy in Industrial and Scientific Applications

Business Wire
·
27 Feb

Bruker Maintains Strong Buy Rating Amidst Innovations in Spatial Biology and Strategic Financial Management

TIPRANKS
·
26 Feb

What Makes Bruker Corporation (BRKR) a Lucrative Investment?

Insider Monkey
·
26 Feb

Frank Laukien Buys Handful Of Shares In Bruker

Simply Wall St.
·
25 Feb

There May Be Reason For Hope In Bruker's (NASDAQ:BRKR) Disappointing Earnings

Simply Wall St.
·
25 Feb

Bruker Advances Single-Cell Proteomics and Immunopeptidomics Performance; Unveils New Proteomics Software and Applications for Enhanced Biological Insights at US HUPO

Business Wire
·
24 Feb